Eight years ago, Bioscience Medical, a company which is part of Bioscience Group, a Swiss holding company, established itself on the world market for premium implants and prostheses. Highly sophisticated, high-quality products are designed and manufactured using state-of-the-art technology, with Tornos machines the sole resource for everything related to priority medical intramedullary rods and screws. The commitment to the patient’s health is demonstrated throughout the life cycle of the product, starting from the use of first-choice materials, which are differentiated by their mechanical, physical and chemical characteristics.

“We are a true Brazilian family business, working in the health sector, with a strong base in Switzerland, where we were immediately given an excellent welcome. From the outset, our goal was to develop a new external fixator for arthroplasty. The parent company, Biomecanica, was founded by my parents, and over the years we have had the opportunity to play an active role in all aspects of orthopaedics in Brazil,” says Ana Carolina Pengo. Biomecanica is an orthopaedic implant and prosthesis company with 34 years of history, trust and transparency.

Biomecanica was the dream of helping patients to get better. With this idea in mind, their president, José Roberto Pengo, took a blank sheet of paper and a pencil and turned these into tools to create an external closure. This fixator was the precursor of this company and continues to provide a source of inspiration because it helps us to envisage dreams and projects, that can become reality, and lead to so many success stories. Biomecanica is more than just square meters of machines and equipment in a factory, it is people with a commitment to health. They carry within them the essence of life. Widely recognized because of the conviction they have demonstrated for so many years, they work to rehabilitate both bodies and minds. “We design our products to better serve the orthopaedic market, and our focus is always on improving the quality of life of our user, the patient!” explains Ana Carolina Pengo.